The expression and refolding of isotopically labeled recombinant Matrilysin for NMR studies

Protein Expression and Purification

Volumn 47, Issue 2, 2006, Pages 367-373

  Ou, Li ^a   Ma, Jinbiao ^a   Zheng, Xunhai ^a   Chen, Xiang ^a   Li, Guangyao ^a   Wu, Houming ^a  

^a SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

Author keywords

Gene synthesis; Isotope labeling; Matrilysin; MMP7; Protein overexpression; Purification; Refolding

Indexed keywords

CARBON; MATRILYSIN; MMP7 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; HUMAN; ISOLATION AND PURIFICATION; ISOTOPE LABELING; MASS SPECTROMETRY; PROTEIN FOLDING;

CARBON ISOTOPES; HUMANS; ISOTOPE LABELING; MATRIX METALLOPROTEINASE 7; PROTEIN FOLDING; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ESCHERICHIA COLI;

EID: 33646568838     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.01.016     Document Type: Article

References (21)

1. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5 (1991) 2145-2154
2. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7 (1995) 728-735
3. Peress N., Perillo E., and Zucker S. Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer's disease and normal brain. J. Neuropathol. Exp. Neurol. 54 (1995) 16-22
4. Stevenson W.G.S., Hewitt R., and Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin. Cancer Biol. 7 (1996) 147-154
5. Leppert D., Lindberg R.L.P., Kappos L., and Leib S.L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res. Rev. 36 (2001) 249-257
6. Ahrens D., Koch A.E., Pope R.M., Stein-Picarella M., and Niedbala M.J. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 39 (1996) 1576-1587
7. Egeblad M., and Werb Z. New function for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
8. Whittaker M., Floyd C.D., Brown P., and Gearing A.J.H. Design and therapeutic application of matrix metalloproteinase inhibitors. Chem. Rev. 99 (1999) 2735-2776
9. Foda H.D., and Zucker S. Matrix metalloproteinases in cancer invasion, metastasis, and angiogenesis. Drug Discov. Today 6 (2001) 478-482
10. Giavazzi R., and Taraboletti G. Preclinical development of metalloproteases inhibitors in cancer therapy. Crit. Rev. Oncol. Hematol. 37 (2001) 53-60
11. Wilson C.L., and Matrisian L.M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel function. Int. J. Biochem. Cell Biol. 28 (1996) 123-136
12. Mitsiades N., Yu W., Poulaki V., Tsokos M., and Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res. 61 (2001) 577-581
13. Davies G., Jiang W.G., and Mason M.D. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells. Clin. Cancer Res. 7 (2001) 3289-3297
14. Wielockx B., Libert C., and Wilson C. Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation. Cytokine Growth Factor Rev. 15 (2004) 111-115
15. Sambrook J., Fritsch E., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, New York
16. Kay L.E., Keifer P., and Saarinen T. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114 (1992) 10663-10665
17. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
18. Johnson B.A., and Blevins R.A. NMRView: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
19. Ernst J.F. Codon usage and gene expression. Trends Biotechnol. 6 (1988) 196-199
20. Hale R.S., and Thompson G. Codon optimization of the gene encoding a domain from human type 1 neurofibromin protein results in a threefold improvement in expression level in Escherichia coli. Protein Expr. Purif. 12 (1998) 185-188
21. Barnett J., Straub K., Nguyen B., Chow J., Suttman R., Thompson K., Tsing S., Benton P., Schatzman R., Chen M., and Chan H. Production, purification, and characterization of human Matrilysin (PUMP) from recombinant Chinese hamster ovary cells. Pept. Expr. Purif. 5 (1994) 27-36